• 1
    Prockop DJ 1997 Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:7174.
  • 2
    Caplan AI 1994 The mesengenic process. Clin Plast Surg 21:429435.
  • 3
    Chen JL, Hunt P, McElvain M, Black T, Kaufman S, Choi ES 1997 Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells 15:368377.
  • 4
    Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF 1997 Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15:546557.
  • 5
    Gerson SL 1999 Mesenchymal stem cells: No longer second class marrow citizens. Nat Med 5:262264.
  • 6
    Caplan AI, Bruder SP 2001 Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259264.
  • 7
    Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK 1999 Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309313.
  • 8
    Pereira R, O'Hara MD, Laptev AV, Halford KW, Pollard MD, Class R, Simon D, Livezey K, Prockop, DJ 1998 Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95:11421147.
  • 9
    Mendes SC, Tibbe JM, Veenhof M, Bakker K, Both S, Plantenburg PP, Oner FC, De Bruijn JD, Van Blintterswijk CA 2002 Bone tissue-engineered implants using human bone marrow stromal cells: Effect of culture conditions and donor age. Tissue Eng 8:911920.
  • 10
    Murphy M 2001 Injected mesenchymal stem cells stimulate meniscal repair and protection of articular cartilage. Trans Orthop Res Soc 26:193.
  • 11
    Lieberman JR, Le LQ, Wu L, Finerman GA, Berk A, Witte ON, Stevenson S 1998 Regional gene therapy with a BMP-2 producing murine stromal cell line induced heterotopic and orthotopic bone formation in rodents. J Orthop Res 16:330339.
  • 12
    Quarto R, Thomas D, Liang CT 1995 Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 56:123129.
  • 13
    Mullender MG, van der Meer DD, Huiskes R, Lips P 1996 Osteocyte density changes in aging and osteoporosis. Bone 18:109113.
  • 14
    Chan GK, Duque G 2002 Age-related bone loss: Old bone, new facts. Gerontology 48:6271.
  • 15
    Mundy GR 2002 Directions of drug discovery in osteoporosis. Annu Rev Med 53:337354.
  • 16
    Rodan GA, Martin TJ 2002 Therapeutic approaches to bone diseases. Science 289:15081514.
  • 17
    Goltzman D 2002 Discoveries, drugs and skeletal disorders. Nat Rev Drug Discov 1:784796.
  • 18
    Reddi AH 1995 Bone morphogenetic proteins, bone marrow stromal cells, and mesenchymal stem cells. Clin Orthop Relat Res 313:115119.
  • 19
    Katagiri T, Takahashi N 2002 Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8:147159.
  • 20
    Lieberman JR, Daluiski A, Einhorn TA 2002 The role of growth factors in the repair of bone. J Bone Joint Surg Am 84:10321044.
  • 21
    Nuttall ME, Gimble JM 2000 Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27:177184.
  • 22
    Meunier P, Aaron J, Edouard C, Vignon G 1971 Osteoporosis and the replacement of cell populations of the marrow by adipose tissue: A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 80:147154.
  • 23
    Burkhardt R, Kettner G, Bohm W, Schmidmeier M, Schlag R, Frisch B, Mallmann B, Eisenmenger W, Gilg TH 1987 Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone 8:157164.
  • 24
    Björkhem I, Diczfalusy U 2002 Oxysterols: Friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol 22:734742.
  • 25
    Edwards PA, Ericsson J 1999 Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68:157185.
  • 26
    Schroepfer GJ 2000 Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol Rev 80:361554.
  • 27
    Russell DW 2000 Oxysterol biosynthetic enzymes. Biochim Biophys Acta 1529:126135.
  • 28
    Lyons MA, Samman S, Gatto L, Brown AJ 1999 Rapid hepatic metabolism of 7-ketocholesterol in vivo: Implications for dietary oxysterols. J Lipid Res 40:18461857.
  • 29
    Björkhem I 2002 Do oxysterols control cholesterol homeostasis? J Clin Invest 110:725730.
  • 30
    Hanley K, Ng DC, He SS, Lau P, Min K, Elias PM, Bikle DD, Mangelsdorf DJ, Williams ML, Feingold KR 2000 Oxysterols induce differentiation in human keratinocytes and increase Ap-1 dependent involucrin transcription. J Invest Dermatol 114:545553.
  • 31
    Kömüves GL, Schmuth M, Fowler AJ, Elias PM, Hanley K, Man M, Moser AH, Lobaccaro JA, Williams ML, Mangelsdorf DJ, Feingold KR 2002 Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-β in murine epidermis. J Invest Dermatol 118:2534.
  • 32
    Hayden JM, Brachova L, Higgins K, Obermiller L, Sevanian A, Khandrika S, Reaven PD 2002 Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J Lipid Res 43:2635.
  • 33
    Parhami F, Mody N, Gharavi N, Ballard AJ, Tintut Y, Demer LL 2002 Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. J Bone Miner Res 17:19972003.
  • 34
    Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL 1999 Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14:20672078.
  • 35
    Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL 1997 Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. Arterioscler Thromb Vasc Biol 17:680687.
  • 36
    Celeste AJ, Rosen V, Buecker JL, Kriz R, Wang EA, Wozney JM 1986 Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J 5:18851890.
  • 37
    Rickard DJ, Sullivan TA, Shenker BJ, LeBoy PS, Kazhdan I 1994 Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218228.
  • 38
    Hicok KC, Thomas T, Gori F, Rickard DJ, Spelsberg TC, Riggs BL 1998 Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res 13:205217.
  • 39
    Stein G, Lian J 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424442.
  • 40
    Zebboudj AF, Imura M, Boström K 2002 Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 277:43884394.
  • 41
    Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:11471156.
  • 42
    Zhang X, Schwartz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ 2002 Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:14051415.
  • 43
    Chikazu D, Li X, Kawaguchi H, Sakuma Y, Voznesensky OS, Adams DJ, Xu M, Hoshi K, Katavic V, Herschman HR, Raisz LG, Pilbeam CC 2002 Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: Role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 17:14301440.
  • 44
    Simon AM, Manigrasso MB, O'Connor JP 2002 Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17:963976.
  • 45
    Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF 2000 Adult human mesenchymal cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:96459652.
  • 46
    Pziros PG, Gil AR, Georgakopoulos T, Habeos I, Kletsas D, Basdra EK, Papavassiliou AG 2002 The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J Biol Chem 277:2393423941.
  • 47
    Pete DJ, Janowski BA, Mangelsdorf DJ 1998 The LXRs: A new class of oxysterol receptors. Curr Opin Genet Dev 8:571575.
  • 48
    Edwards PA, Kast HR, Anisfeld AM 2002 BAREing it all: The adoption of LXR and FXR and their roles in lipid metabolism. J Lipid Res 43:212.
  • 49
    De Mora JF, Porras A, Ahn N, Santos E 1997 Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adiopocytic differentiation. Mol Cell Biol 17:60686075.
  • 50
    Kim S, Muise AM, Lyons PJ, Ro H 2001 Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation. J Biol Chem 276:1019910206.
  • 51
    Hansen JB, Petersen RK, Jørgensen C, Kristiansen K 2002 Deregulated MAPK activity prevents adipocyte differentiation of fibroblasts lacking the retinoblastoma protein. J Biol Chem 277:2633526339.
  • 52
    Raisz LG, Pilbeam CC, Fall PM 1993 Prostaglandins: Mechanisms of action and regulation of production in bone. Osteoporos Int 3(Suppl 1):136140.
  • 53
    Balsinde J, Winstead MV, Dennis EA 2002 Phospholipase A2 regulation of arachidonic acid metabolism. FEBS Lett 531:26.
  • 54
    Capper EA, Marshall LA 2001 Mammalian phospholipases A2: Mediators of inflammation, proliferation and apoptosis. Prog Lipid Res 40:167197.
  • 55
    Lahoua Z, Astruc ME, Barjon JN, Michel F, de Paulet Crastes A 1989 Mechanism of the activation of arachidonic acid release by oxysterols in NRK 49F cells: Role of calcium. Cell Signal 1:569576.
  • 56
    Lahoua Z, Vial H, Michel F, de Paulet Crastes A, Astruc ME 1991 Oxysterol activation of arachidonic acid release and prostaglandin E2 biosynthesis in NRK 49F cells is partially dependent on protein kinase C activity. Cell Signal 3:559567.
  • 57
    Wohlfeil ER, Campbell WB 1997 25-Hydroxycholesterol enhances eicosanoid production in cultured bovine coronary artery endothelial cells by increasing prostaglandin G/H synthase-2. Biochim Biophys Acta 1345:109120.
  • 58
    Lai C, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng S 2001 Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:1444314450.
  • 59
    Urist MR, Behnam K, Kerendi F, Raskin K, Nuygen TD, Shamie AN, Malinin TI 1997 Lipids closely associated with bone morphogenetic protein (BMP) and induced heterotopic bone formation. Connect Tissue Res 36:920.
  • 60
    Lane JM, Boskey AL, Li WKP, Eaton B, Posner AS 1979 A temporal study of collagen, proteoglycan, lipid and mineral constituents in a model of endochondral osseous repair. Metab Bone Dis Relat Res 1:319324.
  • 61
    Bonyadi M, Waldman SD, Liu D, Aubin JE, Grynpas MD, Stanford WL 2003 Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Nat Acad Sci USA 13:58405845.
  • 62
    Ichioka N, Inaba M, Kushida T, Esumi T, Takahara K, Inaba K, Ogawa R, Iida H, Ikehara S 2002 Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells 20:542551.
  • 63
    Chen XD, Shi S, Xu T, Robey PG, Young MF 2002 Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res 17:331340.
  • 64
    Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I 2002 Adipogenesis and aging: Does aging make fat go MAD? Exp Gerontol 37:757767.